Alexion Pharmaceuticals

London Exchange

AstraZeneca complete acquisition of Alexion Pharmaceuticals
ByNNR July 21, 2021October 24, 2023

LONDON, UK: AstraZeneca today completed the acquisition of Alexion Pharmaceuticals Inc. The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca. AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement-biology platform and robust pipeline, will continue to…

Read More AstraZeneca complete acquisition of Alexion Pharmaceuticals
Wire

AstraZeneca signs definitive agreement to acquire Alexion Pharmaceuticals
ByNNR December 13, 2020December 13, 2020

CAMBRIDGE: AstraZeneca and Alexion Pharmaceuticals Inc. have entered into a definitive agreement for AstraZeneca to acquire Alexion, a news release said. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each…

Read More AstraZeneca signs definitive agreement to acquire Alexion Pharmaceuticals